SARS-CoV-2's evolutionary capacity is mostly driven by host antiviral molecules

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Evolutionary Biology

Medicine

Pathology

Genetics And Genomics

Show all topics

DOI

10.1101/2023.04.07.536037

License

CC-BY-NC-ND

Other Formats

PDF